174 related articles for article (PubMed ID: 30995453)
1. Intra-articular botulinum toxin type A for treatment of knee osteoarthritis: Clinical trial.
Najafi S; Sanati E; Khademi M; Abdorrazaghi F; Mofrad RK; Rezasoltani Z
Toxicon; 2019 Jul; 165():69-77. PubMed ID: 30995453
[TBL] [Abstract][Full Text] [Related]
2. Physical therapy, intra-articular dextrose prolotherapy, botulinum neurotoxin, and hyaluronic acid for knee osteoarthritis: randomized clinical trial.
Rezasoltani Z; Azizi S; Najafi S; Sanati E; Dadarkhah A; Abdorrazaghi F
Int J Rehabil Res; 2020 Sep; 43(3):219-227. PubMed ID: 32776763
[TBL] [Abstract][Full Text] [Related]
3. Effect of therapeutic exercise on knee osteoarthritis after intra-articular injection of botulinum toxin type A, hyaluronate or saline: A randomized controlled trial.
Bao X; Tan JW; Flyzik M; Ma XC; Liu H; Liu HY
J Rehabil Med; 2018 Jun; 50(6):534-541. PubMed ID: 29664106
[TBL] [Abstract][Full Text] [Related]
4. Long term effects of intra-articular botulinum toxin A for refractory joint pain.
Mahowald ML; Singh JA; Dykstra D
Neurotox Res; 2006 Apr; 9(2-3):179-88. PubMed ID: 16785116
[TBL] [Abstract][Full Text] [Related]
5. The efficacy and safety of Botulinum Toxin Type A in painful knee osteoarthritis: a systematic review and meta-analysis.
Zhai S; Huang B; Yu K
J Int Med Res; 2020 Apr; 48(4):300060519895868. PubMed ID: 31884849
[TBL] [Abstract][Full Text] [Related]
6. Efficacy of intra-articular botulinum toxin type A in painful knee osteoarthritis: a pilot study.
Boon AJ; Smith J; Dahm DL; Sorenson EJ; Larson DR; Fitz-Gibbon PD; Dykstra DD; Singh JA
PM R; 2010 Apr; 2(4):268-76. PubMed ID: 20430328
[TBL] [Abstract][Full Text] [Related]
7. Botulinum toxin type A for chronic pain and pelvic floor spasm in women: a randomized controlled trial.
Abbott JA; Jarvis SK; Lyons SD; Thomson A; Vancaille TG
Obstet Gynecol; 2006 Oct; 108(4):915-23. PubMed ID: 17012454
[TBL] [Abstract][Full Text] [Related]
8. Decreased flexion contracture after total knee arthroplasty using Botulinum toxin A: a randomized controlled trial.
Smith EB; Shafi KA; Greis AC; Maltenfort MG; Chen AF
Knee Surg Sports Traumatol Arthrosc; 2016 Oct; 24(10):3229-3234. PubMed ID: 27515301
[TBL] [Abstract][Full Text] [Related]
9. Anterior knee pain caused by patellofemoral pain syndrome can be relieved by Botulinum toxin type A injection.
Chen JT; Tang AC; Lin SC; Tang SF
Clin Neurol Neurosurg; 2015 Feb; 129 Suppl 1():S27-9. PubMed ID: 25683309
[TBL] [Abstract][Full Text] [Related]
10. Efficacy of Intra-Articular Botulinum Toxin in Osteoarticular Joint Pain: A Meta-Analysis of Randomized Controlled Trials.
Courseau M; Salle PV; Ranoux D; de Pouilly Lachatre A
Clin J Pain; 2018 Apr; 34(4):383-389. PubMed ID: 28731959
[TBL] [Abstract][Full Text] [Related]
11. Intra-articular botulinum toxin A for base-of-thumb osteoarthritis: protocol for a randomised trial (RHIBOT).
Gil C; Abdoul H; Campagna R; Guerini H; Ieong E; Chagny F; Bedin C; Roren A; Lefèvre-Colau MM; Poiraudeau S; Feydy A; Rannou F; Nguyen C
BMJ Open; 2018 Jun; 8(6):e022337. PubMed ID: 29961037
[TBL] [Abstract][Full Text] [Related]
12. Therapeutic effects of intra-articular botulinum neurotoxin in advanced knee osteoarthritis.
Chou CL; Lee SH; Lu SY; Tsai KL; Ho CY; Lai HC
J Chin Med Assoc; 2010 Nov; 73(11):573-80. PubMed ID: 21093825
[TBL] [Abstract][Full Text] [Related]
13. Efficacy of botulinum toxin type A treatment of functional impairment of degenerative hip joint: Preliminary results.
Marchini C; Acler M; Bolognari MA; Causero A; Volpe D; Regis D; Rizzo A; Rosa R; Eleopra R; Manganotti P
J Rehabil Med; 2010 Jul; 42(7):691-3. PubMed ID: 20603701
[TBL] [Abstract][Full Text] [Related]
14. Intra-articular knee joint Botox injection for chronic osteoarthritic pain.
Goyal N
Anaesth Intensive Care; 2008 Jan; 36(1):123. PubMed ID: 18326148
[No Abstract] [Full Text] [Related]
15. Intra-articular injections of botulinum toxin a for refractory joint pain: a systematic review and meta-analysis.
Wu T; Song HX; Dong Y; Ye Y; Li JH
Clin Rehabil; 2017 Apr; 31(4):435-443. PubMed ID: 27094033
[TBL] [Abstract][Full Text] [Related]
16. [Botulinum toxin treatment of hip adductor spasticity in multiple sclerosis].
Wissel J; Entner T
Wien Klin Wochenschr; 2001; 113 Suppl 4():20-4. PubMed ID: 15506048
[TBL] [Abstract][Full Text] [Related]
17. Intra-articular botulinum toxin A (BoNT/A) for pain management in dogs with osteoarthritis secondary to hip dysplasia: A randomized controlled clinical trial.
Nicácio GM; Luna SPL; Cavaleti P; Cassu RN
J Vet Med Sci; 2019 Mar; 81(3):411-417. PubMed ID: 30643103
[TBL] [Abstract][Full Text] [Related]
18. A randomized saline-controlled trial of NASHA hyaluronic acid for knee osteoarthritis.
Arden NK; Åkermark C; Andersson M; Todman MG; Altman RD
Curr Med Res Opin; 2014 Feb; 30(2):279-86. PubMed ID: 24168077
[TBL] [Abstract][Full Text] [Related]
19. Low-dose botulinum toxin type A for the treatment of refractory piriformis syndrome.
Yoon SJ; Ho J; Kang HY; Lee SH; Kim KI; Shin WG; Oh JM
Pharmacotherapy; 2007 May; 27(5):657-65. PubMed ID: 17461700
[TBL] [Abstract][Full Text] [Related]
20. Safety and performance of Hydros and Hydros-TA for knee osteoarthritis: a prospective, multicenter, randomized, double-blind feasibility trial.
Petrella RJ; Emans PJ; Alleyne J; Dellaert F; Gill DP; Maroney M
BMC Musculoskelet Disord; 2015 Mar; 16():57. PubMed ID: 25887932
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
